Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / fda-extension-request-letter.docx
fda-extension-request-letter.docx
High · 0
Medium · 0
Standard · 0
PENTERRA PHARMACEUTICALS CORP. 480 Overlook Drive, Suite 700 Summit, NJ 07901 (NYSE: PTPH)
PENTERRA PHARMACEUTICALS CORP. 480 Overlook Drive, Suite 700 Summit, NJ 07901 (NYSE: PTPH) November 1, 2023 Dr. Carla M. Witherspoon, Pharm.D. Regulatory Review Officer Office of Prescription Drug Promotion (OPDP) Center for Drug Evaluation and Research (CDER) U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993-0002 Re: Request for Extension of Response Deadline Inquiry Reference Numb